Intracerebral metastases medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
==References== | ==References== | ||
{{reflist|2}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 14:57, 9 November 2015
|
Intracerebral metastases Microchapters |
|
Differentiating Intracerebral Metastases from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Intracerebral metastases medical therapy On the Web |
|
American Roentgen Ray Society Images of Intracerebral metastases medical therapy |
|
Risk calculators and risk factors for Intracerebral metastases medical therapy |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Medical Therapy
Symptomatic: Corticosteroids are given to limit the effects of peritumoral edema. Hyperosmolar agents (eg mannitol) can be given to decrease ICP and anticonvulsants are given to prevent seizures. Recently, methylphenidate and donepezil have been used to improve cognition, mood and quality of life.
Therapeutic: Radiation (whole brain external beam or stereotactic for smaller masses), chemotherapy and surgical resection are done to prolong survival and palliate symptoms. Other than germ cell tumors, leukemias and lymphomas, palliation is the rule and curative therapy is the subject of case reports.